Disclaimer

mannitol-injectable, Osmitrol (cont.)

DRUG INTERACTIONS: Tell your doctor of all prescription and nonprescription medication you may use, especially: lithium, aminoglycoside antibiotics (e.g., gentamicin, kanamycin, tobramycin). Do not start or stop any medicine without doctor or pharmacist approval.

OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include: decrease in amount of urine, seizures, severe trouble breathing.

NOTES: Do not share this medication with others. Laboratory and/or medical tests (e.g., renal function, fluid/electrolytes balance) may be performed to monitor your progress.

MISSED DOSE: If your dose is interrupted or stopped, consult your doctor to establish a new dosing schedule/IV rate.

STORAGE: Store at room temperature between 56 and 86 degrees F (13 to 30 degrees C) away from light. Do not refrigerate or freeze.


Last Editorial Review: 3/2/2005



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index

copyright


STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!